Publications for Alejandro Gugliucci alejandro.gugliucci@tu.edu
Aggarwal, N., Liao, K., Caccavello, R., Kimura, S., & Gugliucci, A. (2014). Oxidative stress and inflammation correlated with lower PON1 lactonase activity in respiratory patients: A pilot study. Journal of the American Osteopathic Association, 114, e84-e117.
Gugliucci, A. (2014). Activation of paraoxonase 1 is associated with HDL remodeling ex vivo. Clinica Chimica Acta, 429, 38-45.
Gugliucci, A., & Menini, T. (2014). The axis AGE-RAGE-soluble RAGE and oxidative stress in chronic kidney disease. In J. Camps (Ed.), Oxidative stress and inflammation in non-communicable diseases - Molecular mechanisms and perspectives in therapeutics (pp. 191-208). Cham, Switzerland: Springer. doi:10.1007/978-3-319-07320-0_14
Gugliucci, A., & Thornburg, R. (2014). Biosynthesis and degradation of nucleotides. In J. W. Baynes & M. H. Dominiczak (Eds.), Medical biochemistry (4th ed., pp. 407-417). Philadelphia, PA: Saunders.
Gugliucci, A., Caccavello, R., Kotani, K., & Kimura, S. (2014). Evidence for the presence of active paraoxonase 1 in small-dense low-density lipoprotein. Redox Report, 19(4), 154-160. doi:10.1179/1351000214Y.0000000084
Gugliucci, A., Caccavello, R., Nassar, H., Abu Ahmad, W., Sinnreich, R., & Kark, J. D. (2014). Lower PON1 lactonase activity explains part of the increased cardiovascular risk among Arab versus Jewish residents of Jerusalem. Atherosclerosis, 235(2), e174. doi:10.1016/j.atherosclerosis.2014.05.505
Gugliucci, A., Kimura, S., & Kinugasa, E. (2014). HDL remodeling during hemodialysis is associated with activation of paraoxonase 1. Atherosclerosis, 235(2), e174. doi:10.1016/j.atherosclerosis.2014.05.506
Gugliucci, A., Kinugasa, E., Ogata, H., Caccavello, R., & Kimura, S. (2014). Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDL. Clinica Chimica Acta, 430, 9-14. doi:10.1016/j.cca.2013.12.027
Gugliucci, A., Kotani, K., Kimura, S., & Menini, T. (2014). Small dense LDL carries active paraoxonase 1. Atherosclerosis, 235(2), e163-e164. doi:10.1016/j.atherosclerosis.2014.05.470
Gugliucci, A., Numaguchi, M., Caccavello, R., & Kimura, S. (2014). Paraoxonase 1 lactonase activity and distribution in the HDL subclasses in the cord blood. Redox Report, 19(3), 124-132. doi:10.1179/1351000213Y.0000000081
Gugliucci, A., Numaguchi, M., Caccavello, R., & Kimura, S. (2014). Small-dense low-density lipoproteins are the predominant apoB-100-containing lipoproteins in cord blood. Clinical Biochemistry, 47(6), 475-477. doi:10.1016/j.clinbiochem.2013.12.009
Jones, G. M., Sinclair, E., Pullinger, C., Caccavello, R., . . . Mulligan, K., Gugliucci, A., Schwarz, J. M. (2014). An immuno-affinity method to separate chylomicrons from VLDL and to ascertain the conversion of sugar to fat by de novo lipogenesis in human intestine. Diabetes, 63(Suppl. 1A), LB58. This material can be found here.
Kotani, K., Caccavello, R., Tsuzaki, K., Sakane, N., & Gugliucci, A. (2014). Short-term effects of pitavastatin treatment on ischemia-modified albumin and modified lipoproteins in patients with hypercholesterolemia. Atherosclerosis, 235(2), e276. doi:10.1016/j.atherosclerosis.2014.05.828
Mak, A. C. Y., Pullinger, C. R., Tang, L. F., Wong, J. S., Deo, R. C., Schwarz, J. M., . . . Gugliucci, A. (2014). Effects of the absence of apolipoprotein E on lipoproteins, neurocognitive function, and retinal function. JAMA Neurology, 71(10), 1228-1236. doi:10.1001/jamaneurol.2014.2011
Menini, T., & Gugliucci, A. (2014). Paraoxonase 1 in neurological disorders. Redox Report, 19(2), 49-58. doi:10.1179/1351000213Y.0000000071
Menini, T., Ikeda, H., Kimura, S., & Gugliucci, A. (2014). Circulating soluble RAGE increase after a cerebrovascular event. Clinical Chemistry and Laboratory Medicine, 52(1), 109-116. doi:10.1515/cclm-2012-0813
Satoh, M., Kotani, K., Gugliucci, A., Horie, H., Caccavello, R., & Takeuchi, M. (2014). Correlation of ischemia-modified albumin with SOFA and APACHE II scores in preoperative patients with colorectal cancer. Scientific World Journal, 2014 [Article 959075]. doi:10.1155/2014/959075
Thornburg, R., and Gugliucci, A. (2014). Deoxyribonucleic acid. In J. W. Baynes & M. H. Dominiczak (Eds)., Medical biochemistry (4th ed., pp. 418-428). Philadelphia, PA: Saunders.
Gugliucci, A. (2013). Bibliometric measures and National Institutes of Health funding at COMs, 2006-2010. Journal of the American Osteopathic Association, 113(4), 266. This material can be found here.
Gugliucci, A., & Camps, J. (2013). New method to assess apo-lipoprotein profiles in native low-density and high-density lipoprotein subclasses. Journal of the American Osteopathic Association, 113(8), e10.
Gugliucci, A., & Kotani, K. (2013). Hyperglycemia induces high-density lipoprotein oxidation: Preliminary evidence from an ex-vivo study. Journal of the American Osteopathic Association, 113(8), e10.
Gugliucci, A., Burk, M., & Caccavello, R. (2013). PON1 lactonase activity and differential distribution in high-density lipoprotein subclasses in the postprandial phase: A pilot study. Journal of the American Osteopathic Association, 113(8), e28.
Gugliucci, A., Caccavello, R., Kotani, K., Sakane, N., & Kimura, S. (2013). Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: A practical zymogram method to assess HDL function. Clinica Chimica Acta, 415, 162-168. doi:10.1016/j.cca.2012.10.044
Kotani, K., Yamada, T., & Gugliucci, A. (2013). Paired measurements of paraoxonase 1 and serum amyloid A as useful disease markers. BioMed Research International, 2013 [Article 481437]. doi:10.1155/2013/481437
Gugliucci, A, Caccavello, R., & Kimura, S. (2012). Soluble receptor for advanced glycation end correlates negatively with BMI in patients with end-stage renal disease undergoing hemodialysis: A mechanism for the obesity paradox? Journal of the American Osteopathic Association, 112(8), 539.
